MedTrace Logo

Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure

NCT03772275 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-12-11

No results posted yet for this study

Summary

Clinical and Economic study of some new biomarkers in chronic heart failure.

Conditions

Interventions

DIAGNOSTIC_TEST

New york Heart Association Class II-IV

New york Heart Association Class II-IV " study of markers"

DIAGNOSTIC_TEST

New york Heart Association Class I

New york Heart Association Class I

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Osama M Ibrahim, Prof · Prof of Clinical Pharmacy

  • Medhat M Eshmawy, Prof · Cardiology Department- Tanta University

  • Nermin W Ishaq, Msc · Clinical pharmacy Department- Tanta University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2026-10-31
Completion
2027-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03772275 on ClinicalTrials.gov